This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside [Yahoo! Finance News]
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: Yahoo! Finance News
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics CAPRH.C. Wainwright’sJoseph Pantginisclick hereSo, what is driving an analyst to set such an extravagant target for such a tiny player? Well, among other reasons, Capricor is one of the companies fighting back against the coronavirus on multiple fronts, both with a search for a vaccine and a possible treatment.Last Friday, Capricor announced that under the compassionate use pathway, CAP-1002, its novel cell therapy currently in clinical development for the treatment of Duchenne muscular dystrophy DMD), is being used to treat patients with advanced COVID-19. So far, two patients at Cedars Sinai Hospital in Los Angeles have received the treatment and both are presently clinically stable.“We note that both patients were in critical condition before receiving CAP-1002 and, according to the compassionate use pathway, they had exhausted all options for treatment. We remind investors that for
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Capricor Therapeutics to Present at Upcoming Investor and Scientific ConferencesGlobeNewswire
- DMD clinical studies evolve with emphasis on building designs around relevant endpoints [Yahoo! Finance]Yahoo! Finance
- Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade [Yahoo! Finance]Yahoo! Finance
- Capricor Therapeutics, Inc. (CAPR) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
CAPR
Earnings
- 8/7/24 - Miss
CAPR
Analyst Actions
- 7/2/24 - HC Wainwright
CAPR
Sec Filings
- 8/23/24 - Form SC
- 8/23/24 - Form 3
- 8/9/24 - Form 4
- CAPR's page on the SEC website